$VRME
VerifyMe Inc Stock $vrme

$vrme Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121465923014701 Filed on November 08, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$8.713M	$5.604M	$5.215M
YoY Change	-10.2%	7.46%	1638.33%
Cost Of Revenue	$5.576M	$3.312M	$3.360M
YoY Change	-18.93%	-1.43%	2847.37%
Gross Profit	$3.137M	$2.292M	$1.855M
YoY Change	11.04%	23.56%	897.31%
Gross Profit Margin	36.0%	40.9%	35.57%
Selling, General & Admin	$2.984M	$3.142M	$2.691M
YoY Change	10.15%	16.76%	187.81%
% of Gross Profit	95.12%	137.09%	145.07%
Research & Development	$84.00K	$5.000K	$39.00K
YoY Change	425.0%	-87.18%	387.5%
% of Gross Profit	2.68%	0.22%	2.1%
Depreciation & Amortization	$294.0K	$300.0K	$261.0K
YoY Change	10.53%	14.94%	800.0%
% of Gross Profit	9.37%	13.09%	14.07%
Operating Expenses	$3.068M	$3.147M	$2.730M
YoY Change	12.59%	15.27%	191.98%
Operating Profit	$69.00K	-$855.0K	-$875.0K
YoY Change	-31.0%	-2.29%	16.82%
Interest Expense	-$132.0K	-$40.00K	-$33.00K
YoY Change	-2740.0%	21.21%	-100.4%
% of Operating Profit	-191.3%
Other Income/Expense, Net	$65.00K	-$75.00K	$318.0K
YoY Change	2066.67%	-123.58%	-96.13%
Pretax Income	$2.000K	-$930.0K	-$557.0K
YoY Change	-98.15%	66.97%	-107.75%
Income Tax
% Of Pretax Income
Net Earnings	$2.000K	-$930.0K	-$557.0K
YoY Change	-98.15%	66.97%	-107.75%
Net Earnings / Revenue	0.02%	-16.6%	-10.68%
Basic Earnings Per Share		-$0.09	-$0.06
Diluted Earnings Per Share	$0.00	-$0.09	-$0.06
COMMON SHARES
Basic Shares Outstanding	9.992M shares	9.900M shares	8.467M shares
Diluted Shares Outstanding		9.879M shares	8.944M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.095M	$3.010M	$3.787M
YoY Change	-9.26%	-20.52%	-64.37%
Cash & Equivalents	$3.032M	$2.944M	$3.694M
Short-Term Investments			$93.00K
Other Short-Term Assets	$254.0K	$300.0K	$190.0K
YoY Change	-23.72%	57.89%	71.17%
Inventory	$38.00K	$42.00K	$141.0K
Prepaid Expenses
Receivables	$3.017M	$1.379M	$1.188M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.686M	$5.615M	$6.001M
YoY Change	-18.74%	-6.43%	-45.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$240.0K	$265.0K	$321.0K
YoY Change	-17.81%	-17.45%	49.3%
Goodwill	$5.384M	$5.313M	$4.092M
YoY Change	35.01%	29.84%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets			$87.00K
YoY Change
Total Long-Term Assets	$13.02M	$13.19M	$11.42M
YoY Change	15.27%	15.5%	-0.62%
TOTAL ASSETS
Total Short-Term Assets	$7.686M	$5.615M	$6.001M
Total Long-Term Assets	$13.02M	$13.19M	$11.42M
Total Assets	$20.71M	$18.81M	$17.42M
YoY Change	-0.23%	7.94%	-22.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.310M	$1.497M	$1.220M
YoY Change	-15.39%	22.7%	181.11%
Accrued Expenses	$988.0K	$815.0K	$486.0K
YoY Change	9.53%	67.7%
Deferred Revenue
YoY Change
Short-Term Debt	$500.0K	$500.0K	$500.0K
YoY Change	0.0%	0.0%
Long-Term Debt Due	$500.0K	$1.000M	$500.0K
YoY Change	0.0%	100.0%
Total Short-Term Liabilities	$5.141M	$3.634M	$2.322M
YoY Change	-5.3%	56.5%	435.02%
LONG-TERM LIABILITIES
Long-Term Debt	$1.975M	$2.100M	$1.500M
YoY Change	43.64%	40.0%
Other Long-Term Liabilities	$1.058M	$1.170M	$387.0K
YoY Change	192.27%	202.33%	4200.0%
Total Long-Term Liabilities	$3.033M	$3.270M	$1.887M
YoY Change	74.61%	73.29%	20866.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.141M	$3.634M	$2.322M
Total Long-Term Liabilities	$3.033M	$3.270M	$1.887M
Total Liabilities	$8.174M	$6.907M	$4.209M
YoY Change	14.07%	64.1%	850.11%
SHAREHOLDERS EQUITY
Retained Earnings	-$81.85M	-$81.85M	-$78.57M
YoY Change	4.32%	4.18%
Common Stock	$10.00K	$10.00K	$10.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$659.0K	$748.0K	$843.0K
YoY Change	-30.56%	-11.27%
Treasury Stock Shares			305.6K shares
Shareholders Equity	$12.53M	$11.90M	$13.21M
YoY Change
Total Liabilities & Shareholders Equity	$20.71M	$18.81M	$17.42M
YoY Change	-0.23%	7.94%	-22.91%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	$2.000K	-$930.0K	-$557.0K
YoY Change	-98.15%	66.97%	-107.75%
Depreciation, Depletion And Amortization	$294.0K	$300.0K	$261.0K
YoY Change	10.53%	14.94%	800.0%
Cash From Operating Activities	$844.0K	-$140.0K	-$43.00K
YoY Change	621.37%	225.58%	-93.86%
INVESTING ACTIVITIES
Capital Expenditures	$116.0K	$210.0K	-$135.0K
YoY Change	0.0%	-255.56%	575.0%
Acquisitions
YoY Change
Other Investing Activities	$1.000K	-$10.00K	$19.00K
YoY Change	-104.76%	-152.63%	-94.65%
Cash From Investing Activities	-$115.0K	-$220.0K	-$116.0K
YoY Change	-16.06%	89.66%	-134.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-646.0K	670.0K	102.0K
YoY Change	145.63%	556.86%	-127.79%
NET CHANGE
Cash From Operating Activities	844.0K	-140.0K	-43.00K
Cash From Investing Activities	-115.0K	-220.0K	-116.0K
Cash From Financing Activities	-646.0K	670.0K	102.0K
Net Change In Cash	83.00K	310.0K	-57.00K
YoY Change	-129.33%	-643.86%	-92.21%
FREE CASH FLOW
Cash From Operating Activities	$844.0K	-$140.0K	-$43.00K
Capital Expenditures	$116.0K	$210.0K	-$135.0K
Free Cash Flow	$728.0K	-$350.0K	$92.00K
YoY Change	72700.0%	-480.43%	-113.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Entity Central Index Key EntityCentralIndexKey	0001104038
CY2022Q4	vrme	Contingent Liability Current ContingentLiabilityCurrent		usd
CY2022Q4	vrme	Contingent Liability Non Current ContingentLiabilityNonCurrent		usd
CY2023Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		usd
CY2022Q4	vrme	Convertible Note Related Party ConvertibleNoteRelatedParty		usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2022Q3	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration		usd
	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration		usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap		usd
	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap		usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax		usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax		usd
	vrme	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration		usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized		usd
	vrme	Leasehold Improvements LeaseholdImprovements		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	vrme	Settlement Of Debt And Redemption Of Shares From Periship Seller SettlementOfDebtAndRedemptionOfSharesFromPerishipSeller		usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	vrme	Initial Recognition Of Rightofuse Asset And Lease Liability During Period InitialRecognitionOfRightofuseAssetAndLeaseLiabilityDuringPeriod		usd
	vrme	Noncash Change In Fair Value Of Interest Rate Swap NoncashChangeInFairValueOfInterestRateSwap		usd
	vrme	Exercise Of Prefunded Warrant ExerciseOfPrefundedWarrant		usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q3	vrme	Sharebased Compensation Arrangement By Sharebased Payment Award Other Than Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1		usd
CY2023Q3	vrme	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39332
	dei	Entity Registrant Name EntityRegistrantName	VERIFYME, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-3023677
	dei	Entity Address Address Line1 EntityAddressAddressLine1	801 International Parkway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Fifth Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	Lake Mary
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32746
	dei	City Area Code CityAreaCode	(585)
	dei	Local Phone Number LocalPhoneNumber	736-9400
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9991806	shares
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3007000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3411000	usd
CY2023Q3	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	76000	usd
CY2022Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	37000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1379000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4448000	usd
CY2023Q3	vrme	Unbilled Revenue UnbilledRevenue	885000	usd
CY2022Q4	vrme	Unbilled Revenue UnbilledRevenue	1185000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	302000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	333000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	42000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	81000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	5615000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9458000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	265000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	292000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	506000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	469000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7107000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6545000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	5313000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	3988000	usd
CY2023Q3	us-gaap	Assets Assets	18806000	usd
CY2022Q4	us-gaap	Assets Assets	20752000	usd
CY2023Q3	us-gaap	Debt Current DebtCurrent	1000000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	500000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1497000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3912000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	815000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	902000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	160000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115000	usd
CY2023Q3	vrme	Contingent Liability Current ContingentLiabilityCurrent	162000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3634000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5429000	usd
CY2023Q3	vrme	Contingent Liability Non Current ContingentLiabilityNonCurrent	827000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	346000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3000	usd
CY2023Q3	vrme	Term Note TermNote	1000000	usd
CY2022Q4	vrme	Term Note TermNote	1375000	usd
CY2023Q3	vrme	Convertible Note Related Party ConvertibleNoteRelatedParty	425000	usd
CY2023Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	675000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	6907000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	7166000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10270400	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9341002	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9935534	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8951035	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	94563000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	92987000	usd
CY2023Q3	vrme	Treasury Stock Share TreasuryStockShare	334866	shares
CY2022Q4	vrme	Treasury Stock Share TreasuryStockShare	389967	shares
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	748000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	949000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-81851000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78459000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-75000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	11899000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13586000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18806000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20752000	usd
CY2023Q3	us-gaap	Revenues Revenues	5604000	usd
CY2022Q3	us-gaap	Revenues Revenues	5215000	usd
	us-gaap	Revenues Revenues	16600000	usd
	us-gaap	Revenues Revenues	9873000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	3312000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	3360000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	10734000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6210000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	2292000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1855000	usd
	us-gaap	Gross Profit GrossProfit	5866000	usd
	us-gaap	Gross Profit GrossProfit	3663000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2754000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2213000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7852000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6213000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	73000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	388000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	478000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1388000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1224000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	3147000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2730000	usd
	us-gaap	Operating Expenses OperatingExpenses	9263000	usd
	us-gaap	Operating Expenses OperatingExpenses	7510000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-855000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-875000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3397000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3847000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-39000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-32000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-127000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-54000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-10964000	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	5000	usd
CY2023Q3	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	-36000	usd
	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	136000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	25000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	28000	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	326000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	326000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-75000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	318000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10659000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-930000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-557000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3392000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14506000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.76
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.76
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9879202	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8943613	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9732619	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8219154	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9879202	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8943613	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9732619	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8219154	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-930000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-557000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3392000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14506000	usd
CY2023Q3	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap	3000	usd
	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap	4000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	28000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	76000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-955000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-557000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3464000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14506000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3392000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14506000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	49000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	13000	usd
	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	46000	usd
	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	123000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	5000	usd
	vrme	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	136000	usd
	vrme	Fair Value Of Restricted Stock Awards And Restricted Stock Units Issued In Exchange For Services FairValueOfRestrictedStockAwardsAndRestrictedStockUnitsIssuedInExchangeForServices	-1053000	usd
	vrme	Fair Value Of Restricted Stock Awards And Restricted Stock Units Issued In Exchange For Services FairValueOfRestrictedStockAwardsAndRestrictedStockUnitsIssuedInExchangeForServices	-972000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	34000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-10964000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	326000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	835000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	504000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-16000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3015000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	69000	usd
	vrme	Oprating Unbilled Revenue OpratingUnbilledRevenue	300000	usd
	vrme	Oprating Unbilled Revenue OpratingUnbilledRevenue	-695000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-38000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	89000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-51000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	33000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2512000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	479000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-599000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2668000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	51000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	33000	usd
	vrme	Leasehold Improvements LeaseholdImprovements	8000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	363000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	7500000	usd
	vrme	Deferred Implementation Costs DeferredImplementationCosts	58000	usd
	vrme	Deferred Implementation Costs DeferredImplementationCosts	87000	usd
	us-gaap	Payments For Software PaymentsForSoftware	576000	usd
	us-gaap	Payments For Software PaymentsForSoftware	127000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1080000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7747000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4528000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	800000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1100000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2000000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	80000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	102000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	18000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	34000	usd
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	10000	usd
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	185000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	675000	usd
	vrme	Settlement Of Debt And Redemption Of Shares From Periship Seller SettlementOfDebtAndRedemptionOfSharesFromPerishipSeller	1724000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1277000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4687000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-404000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5728000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3411000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9422000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3007000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3694000	usd
	us-gaap	Interest Paid Net InterestPaidNet	129000	usd
	vrme	Initial Recognition Of Rightofuse Asset And Lease Liability During Period InitialRecognitionOfRightofuseAssetAndLeaseLiabilityDuringPeriod	552000	usd
	vrme	Noncash Change In Fair Value Of Interest Rate Swap NoncashChangeInFairValueOfInterestRateSwap	4000	usd
	vrme	Exercise Of Prefunded Warrant ExerciseOfPrefundedWarrant	1000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13590000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	33000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	289000	usd
CY2022Q3	vrme	Stock Purchase Plan StockPurchasePlan	31000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	35000	usd
CY2022Q3	vrme	Common Stock Issued In Relation To Private Placement CommonStockIssuedInRelationToPrivatePlacement	-24000	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	185000	usd
CY2022Q3	vrme	Exercise Of Prefunded Warrants ExerciseOfPrefundedWarrants	1000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-557000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	13213000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	12358000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	170000	usd
CY2023Q3	vrme	Restricted Stock Units Net Of Shares Withheld For Employee Tax RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax	308000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	18000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-25000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-930000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	11899000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21167000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	172000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	766000	usd
	vrme	Stock Purchase Plan StockPurchasePlan	98000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	102000	usd
	vrme	Common Stock Issued In Relation To Private Placement CommonStockIssuedInRelationToPrivatePlacement	4528000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	96000	usd
	vrme	Common Stock Issued In Relation To Acquisition CommonStockIssuedInRelationToAcquisition	974000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	185000	usd
	vrme	Exercise Of Prefunded Warrants ExerciseOfPrefundedWarrants	1000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14506000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	13213000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13586000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	317000	usd
	vrme	Restricted Stock Units Net Of Shares Withheld For Employee Tax RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax	718000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	127000	usd
	vrme	Common Stock Issued In Relation To Acquisition CommonStockIssuedInRelationToAcquisition	625000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-72000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3392000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	11899000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zq82a4Hpb3m4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i><span style="text-decoration: underline"><span id="xdx_86C_zZwRceyHFkZc">Reclassifications</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Certain amounts presented for the three and nine months ended September 30, 2022, reflect reclassifications made to conform to the presentation in our current reporting period. These reclassifications had no effect on the previously reported net loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q3	vrme	Equity Investments Fair Value1 EquityInvestmentsFairValue1	98000	usd
CY2022Q4	vrme	Equity Investments Fair Value1 EquityInvestmentsFairValue1	100000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2944000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3348000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	63000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	63000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3007000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3411000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	63000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	63000	usd
CY2023Q3	us-gaap	Revenues Revenues	5604000	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss After Tax ForeignCurrencyTransactionGainLossAfterTax	16000	usd
	us-gaap	Foreign Currency Transaction Gain Loss After Tax ForeignCurrencyTransactionGainLossAfterTax	30000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zxxBIwUisY08" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_865_zpM06SIzLnM5">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p>
CY2022Q3	us-gaap	Revenues Revenues	5215000	usd
	us-gaap	Revenues Revenues	16600000	usd
	us-gaap	Revenues Revenues	9873000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	266000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	248000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	761000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	446000	usd
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8385000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8385000	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4852000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4852000	shares
CY2023Q3	vrme	Equity Investments Fair Value EquityInvestmentsFairValue	0	usd
	vrme	Unrealized Fair Value Loss UnrealizedFairValueLoss	2000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1185000	usd
	vrme	Contract Asset Additions ContractAssetAdditions	2316000	usd
	vrme	Contract Asset Additions ContractAssetAdditions	1317000	usd
	vrme	Reclassification To Accounts Receivable Billed To Customers ReclassificationToAccountsReceivableBilledToCustomers	-2616000	usd
	vrme	Reclassification To Accounts Receivable Billed To Customers ReclassificationToAccountsReceivableBilledToCustomers	-622000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	885000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	695000	usd
CY2023Q1	vrme	Business Combination Consideration Transferred BusinessCombinationConsiderationTransferred	360000	usd
CY2023Q1	vrme	Earnout Consideration EarnoutConsideration	1100000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	219000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	162000	usd
CY2023Q1	vrme	Business Combination Long Term Contingent Consideration BusinessCombinationLongTermContingentConsideration	827000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	3988000	usd
	us-gaap	Acquisition Costs AcquisitionCosts	1383000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-58000	usd
CY2023Q3	us-gaap	Goodwill Gross GoodwillGross	5313000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8918000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1811000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7107000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7613000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1068000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6545000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	291000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1137000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1112000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1108000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1073000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2386000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7107000	usd
CY2023Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	177000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	325000	usd
CY2022Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	33000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	206000	usd
CY2023Q3	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	316000	usd
	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	728000	usd
CY2022Q3	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	289000	usd
	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	766000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	5000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	46000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	31000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	98000	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	334866	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	389967	shares
CY2023Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	748000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	949000	usd
CY2023Q3	vrme	Nonqualified Stock Purchase Plan NonqualifiedStockPurchasePlan	12802	shares
CY2023Q3	vrme	Nonqualified Stock Purchase Exercise Price NonqualifiedStockPurchaseExercisePrice	0.96
CY2023Q1	vrme	Nonqualified Stock Purchase Plan NonqualifiedStockPurchasePlan	57245	shares
CY2023Q1	vrme	Nonqualified Stock Purchase Exercise Price NonqualifiedStockPurchaseExercisePrice	1.19
CY2022Q3	vrme	Nonqualified Stock Purchase Plan NonqualifiedStockPurchasePlan	28895	shares
CY2022Q3	vrme	Nonqualified Stock Purchase Exercise Price NonqualifiedStockPurchaseExercisePrice	1.20
CY2022Q1	vrme	Nonqualified Stock Purchase Plan NonqualifiedStockPurchasePlan	25000	shares
CY2022Q1	vrme	Nonqualified Stock Purchase Exercise Price NonqualifiedStockPurchaseExercisePrice	2.69
CY2022Q3	us-gaap	Accelerated Share Repurchases Adjustment To Recorded Amount AcceleratedShareRepurchasesAdjustmentToRecordedAmount	1500000	usd
CY2023Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	6201	shares
CY2023Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	10000	usd
CY2023Q3	vrme	Unrecognized Compensation Cost Outstanding UnrecognizedCompensationCostOutstanding	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	5103455	shares
CY2022Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	4.34
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	474869	shares
	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice	6.34
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	4628586	shares
CY2023Q3	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	4.13
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y6M
CY2023Q3	vrme	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	4628586	shares
CY2023Q3	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	4.13
	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms	P2Y6M
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	500000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	1000000.0	usd
	vrme	Principal Outstanding PrincipalOutstanding	375000	usd
CY2023Q3	us-gaap	Line Of Credit LineOfCredit	800000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	300000	usd
	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	500000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1958000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.07602	pure
CY2023Q3	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	1100000	usd
CY2023Q3	vrme	Convertiable Promissory Notes Purchased By Related Party ConvertiablePromissoryNotesPurchasedByRelatedParty	425000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	9000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	9000	usd
CY2023Q3	us-gaap	Convertible Debt ConvertibleDebt	1100000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2023Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2023Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	701000	usd
	vrme	Property Plant And Equipment Estimated Useful Lives1 PropertyPlantAndEquipmentEstimatedUsefulLives1	P15Y
CY2023Q1	us-gaap	Goodwill Goodwill	1383000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	47000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	32000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	132000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	53000	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5000	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	23000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	11000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	52000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	36000	usd
	us-gaap	Lease Cost LeaseCost	155000	usd
	us-gaap	Lease Cost LeaseCost	64000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	506000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	469000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	160000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	346000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	506000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	474000	usd
CY2023Q3	vrme	Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities	138000	usd
CY2022Q4	vrme	Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities	80000	usd
CY2022Q4	vrme	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities	552000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M18D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.064	pure
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	36000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	188000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	193000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	139000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	45000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	601000	usd
CY2023Q3	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	95000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	506000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	160000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	346000	usd
CY2023Q3	us-gaap	Revenues Revenues	5604000	usd
CY2022Q3	us-gaap	Revenues Revenues	5215000	usd
	us-gaap	Revenues Revenues	16600000	usd
	us-gaap	Revenues Revenues	9873000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	2292000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1855000	usd
	us-gaap	Gross Profit GrossProfit	5866000	usd
	us-gaap	Gross Profit GrossProfit	3663000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2754000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2213000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7852000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6213000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	73000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	388000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	478000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1388000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1224000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-855000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-875000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3397000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3847000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-75000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	318000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10659000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-930000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-557000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3392000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14506000	usd
CY2023Q3	us-gaap	Assets Assets	18806000	usd
CY2022Q4	us-gaap	Assets Assets	20752000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001214659-23-014701-index-headers.html	Edgar Link	pending
0001214659-23-014701-index.html	Edgar Link	pending
0001214659-23-014701.txt	Edgar Link	pending
0001214659-23-014701-xbrl.zip	Edgar Link	pending
ex10_1.htm	Edgar Link	pending
ex10_2.htm	Edgar Link	pending
ex10_3.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
p100323410q.htm	Edgar Link	pending
pnc_logo.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
p100323410q_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vrme-20230930.xsd	Edgar Link	pending
vrme-20230930_def.xml	Edgar Link	unprocessable
vrme-20230930_cal.xml	Edgar Link	unprocessable
vrme-20230930_lab.xml	Edgar Link	unprocessable
vrme-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRME
VerifyMe Inc Stock $vrme

2023 Q4 Form 10-Q Financial Statement

#000121465923014701 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRME VerifyMe Inc Stock $vrme

2023 Q4 Form 10-Q Financial Statement

#000121465923014701 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRME
VerifyMe Inc Stock $vrme